
ZappRX raises $5.6M Series A as pharma becomes more responsive to specialty drug support needs
ZappRx(Opens in a new window) has raised a Series A round to support sales and product development for its specialty pharmaceutical portal. SR One(Opens in a new window), the venture arm of GlaxoSmithKline(Opens in a new window), led the $5.6 million fundraise, along with Atlas Venture(Opens in a new window). It also added former Teva Pharmaceuticals […]